Centaurus Financial, Inc. Dexcom Inc Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Centaurus Financial, Inc. holds 2,400 shares of DXCM stock, worth $192,576. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,612 8.12%

Holding current value

$192,576

Previous $296,000 45.95%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$64.0 - $116.06 $13,568 - $24,604	-212 Reduced 8.12%	2,400 $160,000
Q2 2024 Sep 20, 2024	BUY	$110.31 - $140.45 $68,943 - $87,781	625 Added 31.45%	2,612 $296,000
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $22,958 - $28,160	201 Added 11.25%	1,987 $275,000
Q4 2023 Feb 26, 2024	SELL	$75.49 - $124.16 $452 - $744	-6 Reduced 0.33%	1,786 $221,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $78,142 - $125,240	-908 Reduced 33.63%	1,792 $167,000
Q2 2023 Aug 15, 2023	BUY	$112.47 - $130.98 $59,046 - $68,764	525 Added 24.14%	2,700 $346,000
Q1 2023 May 17, 2023	BUY	$104.0 - $122.92 $728 - $860	7 Added 0.32%	2,175 $253,000
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $96,962 - $139,966	-1,141 Reduced 34.48%	2,168 $245,000
Q3 2022 Dec 05, 2022	BUY	$76.35 - $94.18 $6,489 - $8,005	85 Added 2.64%	3,309 $267,000
Q2 2022 Aug 02, 2022	BUY	$67.99 - $132.89 $135,164 - $264,185	1,988 Added 160.84%	3,224 $240,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $6,021 - $8,332	64 Added 5.46%	1,236 $632,000
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $7,142 - $8,955	55 Added 4.92%	1,172 $629,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $1,067 - $1,431	10 Added 0.9%	1,117 $611,000
Q2 2021 Aug 10, 2021	BUY	$80.99 - $107.93 $2,672 - $3,561	33 Added 3.07%	1,107 $473,000
Q1 2021 Apr 30, 2021	BUY	$84.79 - $104.74 $2,034 - $2,513	24 Added 2.29%	1,074 $386,000
Q4 2020 Jan 25, 2021	BUY	$78.0 - $104.5 $1,950 - $2,612	25 Added 2.44%	1,050 $388,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $65,615 - $77,596	687 Added 203.25%	1,025 $423,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $21,185 - $35,604	338 New	338 $137,000
Q3 2018 Nov 05, 2018	SELL	$23.35 - $36.72 $326 - $514	-14 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$17.54 - $25.22 $245 - $353	14 New	14 $1,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Dexcom Inc Transaction History